Spectrum Pharmaceutecals Inc (SPPI)

[Tartiaboy]

Excellent background work Antihama. I'm looking forward to the Pozi + T-DM1 data presentation by MDACC at the end of the month. I actually think it could lead to a pop in PPS. Not sure it will hold as combination clinical data is at least a couple years away.

As long as Poziotinib remains the best in class TKR candidate we are golden. But it's going to be a slow process and roll out of full value. Unless we get a buy out.